Genzyme, Alnylam Expand Collaboration on Rare Genetic Diseases
January 13, 2014 at 05:54 AM EST
Genzyme, a Sanofi company (NYSE: SNY ), and Alnylam Pharmaceuticals (NASDAQ: ALNY ) announced today that they have significantly expanded their strategic agreement to develop and commercialize